LLY

1,080.21

+1.73%↑

JNJ

223.5

+0.31%↑

ABBV

217.16

+0.73%↑

UNH

377.97

+0.23%↑

MRK

114.86

-0.95%↓

LLY

1,080.21

+1.73%↑

JNJ

223.5

+0.31%↑

ABBV

217.16

+0.73%↑

UNH

377.97

+0.23%↑

MRK

114.86

-0.95%↓

LLY

1,080.21

+1.73%↑

JNJ

223.5

+0.31%↑

ABBV

217.16

+0.73%↑

UNH

377.97

+0.23%↑

MRK

114.86

-0.95%↓

LLY

1,080.21

+1.73%↑

JNJ

223.5

+0.31%↑

ABBV

217.16

+0.73%↑

UNH

377.97

+0.23%↑

MRK

114.86

-0.95%↓

LLY

1,080.21

+1.73%↑

JNJ

223.5

+0.31%↑

ABBV

217.16

+0.73%↑

UNH

377.97

+0.23%↑

MRK

114.86

-0.95%↓

Search

Guardant Health Inc

Затворен

СекторЗдравеопазване

126.95 -2.27

Преглед

Промяна на цената на акция

24 ч

Текуща

Минимум

125.2

Максимум

129.77

Ключови измерители

By Trading Economics

Приходи

16M

-112M

Продажби

20M

302M

EPS

-0.45

Марж на печалбата

-37.152

Служители

2,490

EBITDA

18M

-101M

Препоръки

By TipRanks

Препоръки

Силна покупка

12-месечна прогноза

+5.2% upside

Дивиденти

By Dow Jones

Следващи печалби

29.07.2026 г.

Пазарни показатели

By TradingEconomics

Пазарна капитализация

5B

17B

Предишно отваряне

129.22

Предишно затваряне

126.95

Настроения в новините

By Acuity

50%

50%

154 / 344 Класиране в Healthcare

Guardant Health Inc Графика

Миналото представяне не гарантира бъдещи резултати.

Свързани новини

3.06.2026 г., 23:22 ч. UTC

Печалби
Значими двигатели на пазара

Broadcom Shares Slide Despite Jump in 2Q Revenue on AI Chip Demand -- Update

3.06.2026 г., 23:09 ч. UTC

Горещи акции

Stocks to Watch: Broadcom, CrowdStrike, PVH, Petco

3.06.2026 г., 20:51 ч. UTC

Печалби

Costco Reports 15% Sales Growth in May

3.06.2026 г., 20:43 ч. UTC

Печалби

Broadcom 2Q Revenue Climbs on AI Chip Demand

3.06.2026 г., 23:48 ч. UTC

Пазарно говорене

Nikkei May Fall Amid Renewed Concerns About Iran Conflict -- Market Talk

3.06.2026 г., 23:48 ч. UTC

Пазарно говорене

Global Forex and Fixed Income Roundup: Market Talk

3.06.2026 г., 23:35 ч. UTC

Пазарно говорене

Oil Futures Fall on Possible Technical Correction -- Market Talk

3.06.2026 г., 23:15 ч. UTC

Пазарно говорене
Печалби

Five Below, Broadcom and Crowdstrike Fall Despite Solid Results -- Market Talk

3.06.2026 г., 22:08 ч. UTC

Горещи акции

After-Hours Stocks to Watch: CrowdStrike, Broadcom, Five Below -- WSJ

3.06.2026 г., 21:54 ч. UTC

Пазарно говорене

Correction to Oil Futures Rise on Concerns About U.S.-Iran Talks Article on June 1

3.06.2026 г., 21:18 ч. UTC

Печалби

Broadcom's Non-AI Semiconductor Revenue Rose 6% in 2Q, CEO Says

3.06.2026 г., 21:15 ч. UTC

Печалби

Broadcom CEO: Google Partnership Continues to Be 'Very Substantial'

3.06.2026 г., 21:13 ч. UTC

Печалби

Broadcom CEO Expects AI Semiconductor Revenue Growth to Continue in Fiscal 2028

3.06.2026 г., 21:13 ч. UTC

Печалби

Broadcom Continues to Expect AI Semiconductor Revenue of More Than $100B in 2027, CEO Says

3.06.2026 г., 21:12 ч. UTC

Печалби

Broadcom Expects AI Semiconductor Revenue of $56B This Year, CEO Says

3.06.2026 г., 21:09 ч. UTC

Печалби

Broadcom CEO: Networking Made Up Almost 40% of AI Revenue in 2Q

3.06.2026 г., 21:03 ч. UTC

Печалби

Broadcom Stock Falls After Earnings. Here's Why. -- Barrons.com

3.06.2026 г., 20:50 ч. UTC

Пазарно говорене

Tech, Media & Telecom Roundup: Market Talk

3.06.2026 г., 20:43 ч. UTC

Печалби

CrowdStrike Stock Falls Despite Earnings Beat -- Barrons.com

3.06.2026 г., 20:39 ч. UTC

Придобивния, сливания и поглъщания

Bill Ackman's Pershing Square Set To Make $600 Million on Universal Stake -- 4th Update

3.06.2026 г., 20:37 ч. UTC

Придобивния, сливания и поглъщания

Bill Ackman's Pershing Square Set To Make $600 Million on Universal Stake -- 3rd Update

3.06.2026 г., 20:35 ч. UTC

Печалби

Broadcom Stock Falls Despite Record Results -- Barrons.com

3.06.2026 г., 20:21 ч. UTC

Придобивния, сливания и поглъщания

Bill Ackman's Pershing Square Set To Make $600 Million on Universal Stake -- 2nd Update

3.06.2026 г., 20:17 ч. UTC

Печалби

Broadcom 2Q Semiconductor Solutions Revenue $15B >AVGO

3.06.2026 г., 20:17 ч. UTC

Печалби

Broadcom Sees 3Q Semiconductor Revenue From AI $16B >AVGO

3.06.2026 г., 20:15 ч. UTC

Придобивния, сливания и поглъщания

Bill Ackman's Pershing Square Set To Make $600 Million on Universal Stake -- Update

3.06.2026 г., 20:15 ч. UTC

Печалби

Broadcom 2Q Adj EPS $2.44 >AVGO

3.06.2026 г., 20:15 ч. UTC

Печалби

Broadcom 2Q EPS $1.91 >AVGO

3.06.2026 г., 20:15 ч. UTC

Пазарно говорене

Global Commodities Roundup: Market Talk

3.06.2026 г., 20:15 ч. UTC

Печалби

Broadcom 2Q Rev $22.19B >AVGO

Сравнение с други в отрасъла

Ценова промяна

Guardant Health Inc Прогноза

Ценова цел

By TipRanks

5.2% нагоре

12-месечна прогноза

Среден 136.94 USD  5.2%

Висок 160 USD

Нисък 120 USD

Според 17 анализатори от Wall Street, предложили 12-месечна ценова цел за Guardant Health Inc през последните три месеца.

Консенсусна оценка

By TipRanks

Силна покупка

17 ratings

17

Купи

0

Задържане

0

Продай

Настроение

By Acuity

154 / 344 Класиране в Здравеопазване

Настроения в новините

Neutral

Волатилност

Под средното

Обем новини (RCV)

Среден

Финанси

Продажбени и админисративни разходи

Оперативни разходи

Печалба преди облагане с данъци

Продажби

Разходи за продажби

Брутна печалба от продажби

Разходи за лихви по дълг

EBITDA

Оперативна печалба

$

Относно Guardant Health Inc

Guardant Health, Inc., a precision oncology company, provides blood and tissue tests, data sets, and analytics in the United States and internationally. The company provides Guardant360; Guardant360 LDT; Guardant360 CDx Test; Guardant360 Response Test; Guardant360 TissueNext Test; GuardantINFINITY Test; GuardantConnect, an integrated software-based solution designed for clinical and biopharmaceutical customers to connect patients tested with assays with actionable alterations with potentially relevant clinical studies; GuardantOMNI Test for advanced stage cancer; and GuardantINFORM, an in-silico research platform for tumor evolution and treatment resistance across various biomarker-driven cancers. It offers Shield Test; Guardant Reveal Test for adjuvant treatment selection in early-stage cancer patients; Smart Liquid Biopsy Platform; and Guardant Galaxy, an AI-backed digital pathology platform that helps improve cancer biomarker detection. In addition, the company offers development services, including companion diagnostic development and regulatory approval, clinical study setup, monitoring and maintenance, testing development and support, technologies licensing, and kits fulfillment. The company has a collaboration agreement with Illumina, Inc. for the sharing of specimen samples to advance cancer research; and with ConcertAI to form first data-as-a-service that integrates clinical and tumor profiling data to accelerate cancer therapy research and development. The company was incorporated in 2011 and is headquartered in Palo Alto, California.
help-icon Live chat